Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Post-approval studies (Phase 4)UnknownNCT00777504
What this trial is testing

Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors

Who this might be right for
Renal Cell CarcinomaGastrointestinal Stromal Tumor
Radboud University Medical Center 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05057494
What this trial is testing

Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
AstraZeneca 607
Testing effectiveness (Phase 2)Study completedNCT01129622
What this trial is testing

Effect of Aromatase Inhibitors on Breast Magnetic Resonance Imaging (MRI)

Who this might be right for
Breast Cancer
Mount Sinai Hospital, Canada 16
Testing effectiveness (Phase 2)UnknownNCT02340845
What this trial is testing

Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans

Who this might be right for
Cancer
Oeyama-Moto Cancer Research Foundation 100
Not applicableStudy completedNCT01139645
What this trial is testing

The Effect of Proton Pump Inhibitors on Calcium and Bone Metabolism

Who this might be right for
Calcium Metabolism Disorders
American University of Beirut Medical Center 58
Post-approval studies (Phase 4)Study completedNCT03175731
What this trial is testing

PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)

Who this might be right for
Liver CirrhosisHypertension, Portal
Yanjing Gao 106
Testing effectiveness (Phase 2)WithdrawnNCT03384095
What this trial is testing

Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias

Who this might be right for
Breast Neoplasm FemaleArthralgia
Erin Newton
Testing effectiveness (Phase 2)Study completedNCT03647839
What this trial is testing

Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Australasian Gastro-Intestinal Trials Group 90
Testing effectiveness (Phase 2)Study completedNCT03922750
What this trial is testing

A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 154
Testing effectiveness (Phase 2)UnknownNCT00299897
What this trial is testing

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Who this might be right for
HIV InfectionsHuman Immunodeficiency Virus
Samaritan Pharmaceuticals, Inc 60
Post-approval studies (Phase 4)WithdrawnNCT04531397
What this trial is testing

Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease

Who this might be right for
ProteinuriaChronic Kidney Diseases
Children's Hospital of Fudan University
Testing effectiveness (Phase 2)UnknownNCT03647956
What this trial is testing

Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase Inhibitors

Who this might be right for
NSCLC Stage IIIBNSCLC Stage IVEGFR Activating Mutation
The University of Hong Kong 40
Not applicableStudy completedNCT00000922
What this trial is testing

Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,710
Not applicableStudy completedNCT00710619
What this trial is testing

Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 52
Testing effectiveness (Phase 2)UnknownNCT06113900
What this trial is testing

Assessment of Safety and Efficacy of SGLT2is Among LN Patients

Who this might be right for
Lupus Nephritis
Ain Shams University 50
Early research (Phase 1)Study completedNCT00002111
What this trial is testing

A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.

Who this might be right for
HIV Infections
Stanford University 32
Not applicableEnded earlyNCT05471271
What this trial is testing

IL-2 PET Imaging in Advanced Solid Tumours

Who this might be right for
Metastatic Solid Tumor
University Medical Center Groningen 1
Large-scale testing (Phase 3)Ended earlyNCT04477993
What this trial is testing

Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2SARS-CoV2
Vanderson Geraldo Rocha 5
Not applicableStudy completedNCT02926456
What this trial is testing

Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)

Who this might be right for
Human Immunodeficiency Virus
Janssen-Cilag S.p.A. 337
Next Page